Javascript must be enabled to continue!
P2X7 channel activity in the vascular endothelium inhibits vasodilation and increases blood pressure
View through CrossRef
High blood pressure, hypertension, is the top risk factor for the leading causes of death, cardiovascular disease and stroke. Blood pressure can be elevated by increasing contractility of resistance-sized arteries. Contractility is increased by depolarization of smooth muscle membrane potential which is regulated by the balance of smooth muscle and endothelial cell resident ion channel activity. P2X7, a non-selective cation channel, is expressed in the endothelium of resistance-sized arteries. We hypothesized that activation of endothelial cell resident P2X7 channels would short-circuit endothelium dependent hyperpolarization and inhibit vasodilation. P2X7 agonists, BzATP and histone proteins, decrease flow-mediated dilation (FMD) when applied directly to the endothelium. Application of an orthosteric P2X7 antagonist, PPADS, increases FMD. Mesenteric resistance-sized arteries from endothelial cell specific P2X7 knockout (P2X7 ecKO) mice have increased FMD, do not constrict to P2X7 agonists during flow, and have decreased histone-induced Ca
2+
influx in en face preparations. This data demonstrates that ecP2X7 activity inhibits vasodilation. To determine if this translates to increased blood pressure, we used tail cuff plethysmography to measure blood pressure in aged P2X7 ecKO and floxed control mice. Aged (9 mth) control animals have elevated blood pressure, consistent with previous reports. P2X7 ecKO mice have decreased blood pressure relative to age-matched floxed control animals, consistent with increased vasodilation in P2X7 ecKO arteries. This data demonstrates that P2X7 activity in the vascular endothelium inhibits vasodilation and increases blood pressure. This may provide new therapeutic strategies to treat hypertension and lessen the burden of cardiovascular disease and stroke.
This abstract was presented at the American Physiology Summit 2026 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.
Title: P2X7 channel activity in the vascular endothelium inhibits vasodilation and increases blood pressure
Description:
High blood pressure, hypertension, is the top risk factor for the leading causes of death, cardiovascular disease and stroke.
Blood pressure can be elevated by increasing contractility of resistance-sized arteries.
Contractility is increased by depolarization of smooth muscle membrane potential which is regulated by the balance of smooth muscle and endothelial cell resident ion channel activity.
P2X7, a non-selective cation channel, is expressed in the endothelium of resistance-sized arteries.
We hypothesized that activation of endothelial cell resident P2X7 channels would short-circuit endothelium dependent hyperpolarization and inhibit vasodilation.
P2X7 agonists, BzATP and histone proteins, decrease flow-mediated dilation (FMD) when applied directly to the endothelium.
Application of an orthosteric P2X7 antagonist, PPADS, increases FMD.
Mesenteric resistance-sized arteries from endothelial cell specific P2X7 knockout (P2X7 ecKO) mice have increased FMD, do not constrict to P2X7 agonists during flow, and have decreased histone-induced Ca
2+
influx in en face preparations.
This data demonstrates that ecP2X7 activity inhibits vasodilation.
To determine if this translates to increased blood pressure, we used tail cuff plethysmography to measure blood pressure in aged P2X7 ecKO and floxed control mice.
Aged (9 mth) control animals have elevated blood pressure, consistent with previous reports.
P2X7 ecKO mice have decreased blood pressure relative to age-matched floxed control animals, consistent with increased vasodilation in P2X7 ecKO arteries.
This data demonstrates that P2X7 activity in the vascular endothelium inhibits vasodilation and increases blood pressure.
This may provide new therapeutic strategies to treat hypertension and lessen the burden of cardiovascular disease and stroke.
This abstract was presented at the American Physiology Summit 2026 and is only available in HTML format.
There is no downloadable file or PDF version.
The Physiology editorial board was not involved in the peer review process.
Related Results
Extracellular human cathelicidin peptide (LL-37) activates P2X7 receptor current
Extracellular human cathelicidin peptide (LL-37) activates P2X7 receptor current
P2X7 is a unique member of the ionotropic purinergic receptor (P2X) family with low affinity for ATP. Increasing evidence suggests that non-nucleotide agonists, such as antimicrobi...
[RETRACTED] Guardian Blood Balance –Feel the difference Guardian Blood Balance makes! v1
[RETRACTED] Guardian Blood Balance –Feel the difference Guardian Blood Balance makes! v1
[RETRACTED]Guardian Blood Balance Reviews (Works Or Hoax) Does Guardian Botanicals Blood Balance AU Really Works? Read Updated Report! Diabetes and Hypertension is such a health p...
CB2/miR-124 signaling down-regulate the expression of purinergic P2X4 and P2X7 receptor in dorsal spinal cord of CCI rats
CB2/miR-124 signaling down-regulate the expression of purinergic P2X4 and P2X7 receptor in dorsal spinal cord of CCI rats
Abstract
Background: The importance of P2X purinoceptors, CB2 receptor and microRNA-124(miR-124) in spinal cord microglia to the development of neuropathic pain was demonst...
Serum P2X7 as a prognostic biomarker in acute supratentorial intracerebral hemorrhage: a two-center observational study
Serum P2X7 as a prognostic biomarker in acute supratentorial intracerebral hemorrhage: a two-center observational study
Introduction
P2X7 participates in neuroinflammation underlying acute brain injury. In this study, we investigated the prognostic role of serum P2X7 in acute int...
P2X7 Receptor–Mediated Inflammatory and Ionic Remodeling Promotes Atrial Fibrillation in Diabetes
P2X7 Receptor–Mediated Inflammatory and Ionic Remodeling Promotes Atrial Fibrillation in Diabetes
AimsDiabetes mellitus (DM) is a major risk factor for atrial fibrillation (AF), yet the mechanisms by which diabetic metabolic stress promotes atrial arrhythmogenesis remain incomp...
P2X7 promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of Pbx3
P2X7 promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of Pbx3
Nucleotides mediate intercellular communication by activating purinergic receptors and take part in various physiological and pathological processes. Abnormal purinergic signaling ...
Dipyridamole Potentiates Pulmonary Vasodilation Induced by Acetylcholine and Nitric Oxide in the Ovine Fetus
Dipyridamole Potentiates Pulmonary Vasodilation Induced by Acetylcholine and Nitric Oxide in the Ovine Fetus
Abstract
Nitric oxide (NO) modulates pulmonary vascular resistance (PVR) in the normal fetus by increasing the cyclic guanosine 3 ′ ,5 ′ -monophosphate (cGMP) con...
P2X7 Variants in Oncogenesis
P2X7 Variants in Oncogenesis
The P2X7 receptor for extracellular ATP is a well-established mediator of tumoral development and progression both in solid cancers and hematological malignancies. The human P2X7 g...

